<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns="http://purl.org/rss/1.0/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel rdf:about="http://repository.usmf.md:80/xmlui/handle/20.500.12710/13577">
<title>The Moldovan Medical Journal, Vol. 60, No 1, February 2017</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/13577</link>
<description/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://repository.usmf.md:80/xmlui/handle/20.500.12710/16255"/>
<rdf:li rdf:resource="http://repository.usmf.md:80/xmlui/handle/20.500.12710/2729"/>
<rdf:li rdf:resource="http://repository.usmf.md:80/xmlui/handle/20.500.12710/2730"/>
<rdf:li rdf:resource="http://repository.usmf.md:80/xmlui/handle/20.500.12710/2732"/>
</rdf:Seq>
</items>
<dc:date>2026-07-28T04:14:26Z</dc:date>
</channel>
<item rdf:about="http://repository.usmf.md:80/xmlui/handle/20.500.12710/16255">
<title>The Moldovan Medical Journal. February 2017, Vol. 60, No 1</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/16255</link>
<description>The Moldovan Medical Journal. February 2017, Vol. 60, No 1
The journal was founded in 1958 on the initiative of Nicolae Testemitsanu, an outstanding expert in orthopedics, social medicine, and public health.&#13;
Now the publisher of the journal is the Scientific Medical Association of Moldova and the journal has become the scientific peer-reviewed periodical Edition&#13;
designed for specialists in the areas of medicine, dentistry, pharmacy, social medicine, and public health. From its debut the journal has striven to support&#13;
the interests of Moldovan medicine concerning the new concepts of its development.&#13;
The aim of the Moldovan Medical Journal is to provide the international community with the results of scientific researches performed in the medical&#13;
institutions of Moldova and inform Moldovan medical society about the advanced achievements of medicine abroad.&#13;
The Editorial Board warmly welcomes both the readers of and the authors of the journal, all those who are enthusiastic about searching for new and more&#13;
effective ways of solving numerous medical problems. We hope that those who want to make their contribution to the science of medicine will find our&#13;
journal helpful and encouraging.
Fondatori: Ministerul Sănătăţii al Republicii Moldova, Universitatea de Stat de Medicină şi Farmacie “Nicolae Testemiţanu”
</description>
<dc:date>2017-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://repository.usmf.md:80/xmlui/handle/20.500.12710/2729">
<title>Experimental study of new 3-(2-R1 -6-R2 -4-oxyquinoline-3(4H)-yl)alkyl (alkaryl-, aryl) carboxylic acid derivative (PC-66 compound)</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/2729</link>
<description>Experimental study of new 3-(2-R1 -6-R2 -4-oxyquinoline-3(4H)-yl)alkyl (alkaryl-, aryl) carboxylic acid derivative (PC-66 compound)
Kramar, Hanna
Background: Screening studies have revealed in new 3-(2-R1-6-R2-4-oxyquinoline-3(4H)-yl)alkyl (alkaryl-, aryl) carboxylic acid derivative (PC-66&#13;
compound) expressive analgesic properties without any damaging effects on the stomach. Therefore, in-depth study of the pharmacological properties&#13;
of PC-66 compound as a pain management agent is considered topical. Objective of the study – to evaluate a pain-killing effect of PC-66 compound&#13;
compared to ketorolac and diclofenac sodium on various rat pain models.&#13;
Material and methods: In experiments on 101 Wistar male rats (180-210 g) of somatic model (tail-flick) and neuropathic pain model (ligation of the&#13;
sciatic nerve), and formalin test (5% formalin solution, 0.1 ml subplantarly) we investigated the antinociceptive activity of the PC-66 compound (1.0 mg/&#13;
kg) versus ketorolac (2.4 mg/kg) and diclofenac (4.0 mg/kg) administered intraperitoneally.&#13;
Results: In the tail-flick model, PC-66 compound presented significant growth of PT at Hour 1 and Hour 2 by 40.6% and 50.6%, respectively. The analgesia&#13;
effect of the test compound was superior to the one of diclofenac sodium, but inferior to ketorolac at Hour 1 and Hour 2, yet surpassed it by duration&#13;
of action. In the formalin test model, analgesic effect of compound PC-66 was the most evident in the first (central) phase, and slightly changed the&#13;
latent period and duration of the second phase of the test, while diclofenac mostly influenced Phase II (inflammatory) of the formalin test. In the model&#13;
of neuropathic pain, compound PC-66 also demonstrated pronounced pain-killing effect: PT of subject rat limb grew on average by 46.7% in 2 hours&#13;
following intraperitoneal administration. For this activity, PC-66 was slightly inferior to ketorolac, which caused PT growth by 51.9%.&#13;
Conclusions: new 3-(2-R1-6-R2-4-oxyquinoline-3(4H)-yl) alkyl (alkaryl-, aryl) carboxylic acid derivative (PC-66 compound) presented distinct analgesic&#13;
effect both in somatic and neuropathic pain models.
Department of Pharmacology, N. I. Pirogov National Medical University of Vinnitsa, Ukraine
</description>
<dc:date>2017-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://repository.usmf.md:80/xmlui/handle/20.500.12710/2730">
<title>Antimicrobial effect of biodegradable wound healing nano-containing polymer materials</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/2730</link>
<description>Antimicrobial effect of biodegradable wound healing nano-containing polymer materials
Popadyuk, Oleh Yaroslavovytch
Background: Treatment of infected wounds presents the biggest difficulty for the surgeon. The treatment of skin lesions has recently increased due to&#13;
the effect of developed local multi-application forms saturated with nano-sized antiseptic preparations, namely with metals nano-oxides: zinc oxide,&#13;
magnesium oxide, iron oxide, silver oxide, etc.&#13;
Material and methods: We have developed a biodegradable polymer film that is flexible and has the ability to biodegrade and deliver the remedy to the&#13;
area of injury. Saturated with active components, polymer films have been studied for their antimicrobial effect against clinical strains of opportunistic&#13;
microorganisms commonly present in wounds, which were isolated from patients with purulent-septic diseases: Staphyloccus aureus, Staphyloccus&#13;
epidermidis, Staphyloccus haemolyticus, Streptococcus pyogenes, Escherichia coli, Citrobacter freundii, Pseudomonas aeruginosa and Candida tropicalis yeasts.&#13;
Results: The films saturated with zinc nano-oxide have been characterized by high antimicrobial effect against all used microbial cultures. Films containing&#13;
5 and 10% of ZnO appeared to produce larger areas of growth inhibition against the most strains in comparison to the films containing 1% of ZnO. In&#13;
contrast to zinc nano-oxide, the presence of magnesium in films hasn’t proved to have any antimicrobial effect.&#13;
Conclusions: Biodegradable films with 5% of nano-oxide content have optimal antimicrobial effect in vitro against relatively opportunistic microorganisms&#13;
and require further experimental and clinical studies.
Department of General Surgery, National Medical University of Ivano-Frankivsk, Ukraine
</description>
<dc:date>2017-01-01T00:00:00Z</dc:date>
</item>
<item rdf:about="http://repository.usmf.md:80/xmlui/handle/20.500.12710/2732">
<title>Infravesical urinary tract obstruction and transurethral endoscopic approach of treatment</title>
<link>http://repository.usmf.md:80/xmlui/handle/20.500.12710/2732</link>
<description>Infravesical urinary tract obstruction and transurethral endoscopic approach of treatment
Ghicavii, Vitalii
Backqround: The results of scientifical progress in recent years have contributed to the development of transurethral endoscopic surgery, with the&#13;
implementation of new methods, less invasive, for the treatment of the lower urinary tract diseases of different genesis. Laser surgery, transurethral&#13;
electorezection, electrovaporization, bipolar surgery (plasmakinetic rezection and vaporization) and the combination of these methods have a number&#13;
of avantages over traditional open interventions and contribute to a significant change in the treatment approach of most urological diseases, including&#13;
those causing infravesical obstruction (IVO).&#13;
Conclusions: The implementation of personalized medicine with correct selecting and pathogenetic motivation of the methods of treatement in&#13;
management of the IVO have been made in several directions: prophylactics, diagnosis and treatment. Medical and social importance, variety of clinic&#13;
manifestations and evolution, evident alternation of quality of life, high cost of diagnostic, conservative management and of surgical treatment determine&#13;
the statuts of infravesical obstruction as a current problem from scientific and practical point of view and motivates the need of a deep study of disorders&#13;
manifested through IVO, minimizing complications and the rate of their relapse.
Department of Urology and Surgical Nephrology, Nicolae Testemitsanu State University of Medicine and Pharmacy, Chisinau, the Republic of Moldova
</description>
<dc:date>2017-01-01T00:00:00Z</dc:date>
</item>
</rdf:RDF>
